To confirm if inhibiting MV-release also can sensitize pancreatic tumor growth in vivo, tumors developed from orthotopically implanted Suit-2-luc or Suit-2T27N-luc cells in mice were treated with GEM in the presence and absence of a MEK inhibitor, AZD6244. This evidence concerns the gene MAP2K7 and pancreatic neoplasm.